The Cardiotonic Agents Market encompasses a diverse spectrum of drug classes, including positive inotropic agents, vasodilators, beta-agonists, and phosphodiesterase inhibitors. Each therapeutic class addresses specific clinical challenges in hemodynamic stabilization and cardiac performance improvement.
Key Drug Delivery Routes
-
Oral Administration: Preferred for chronic disease management and long-term outpatient maintenance, offering greater convenience and patient compliance.
-
Intravenous (IV) Administration: Essential in acute clinical settings, emergency departments, and intensive care units where rapid therapeutic onset is required.
-
Subcutaneous Delivery: Emerging as an alternative pathway for specialized patient populations requiring continuous or semi-continuous administration outside hospital settings.
